Cargando…

Detailed Evaluation of Chromatic Pupillometry and Full-Field Stimulus Testing to Assess Ultralow Vision in Retinitis Pigmentosa

PURPOSE: Novel therapeutic options, such as regenerative medicine and gene therapy, are now emerging as viable treatment options for patients with severe visual impairments, such as retinitis pigmentosa (RP). Gradable assessment of patients’ visual function is essential to consider treatment options...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Midori, Matsuyama, Take, Maeda, Tadao, Takagi, Seiji, Motozawa, Naohiro, Sakai, Daiki, Hirami, Yasuhiko, Maeda, Akiko, Kurimoto, Yasuo, Takahashi, Masayo, Mandai, Michiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618823/
https://www.ncbi.nlm.nih.gov/pubmed/37920419
http://dx.doi.org/10.1016/j.xops.2023.100328
_version_ 1785129859482124288
author Yamamoto, Midori
Matsuyama, Take
Maeda, Tadao
Takagi, Seiji
Motozawa, Naohiro
Sakai, Daiki
Hirami, Yasuhiko
Maeda, Akiko
Kurimoto, Yasuo
Takahashi, Masayo
Mandai, Michiko
author_facet Yamamoto, Midori
Matsuyama, Take
Maeda, Tadao
Takagi, Seiji
Motozawa, Naohiro
Sakai, Daiki
Hirami, Yasuhiko
Maeda, Akiko
Kurimoto, Yasuo
Takahashi, Masayo
Mandai, Michiko
author_sort Yamamoto, Midori
collection PubMed
description PURPOSE: Novel therapeutic options, such as regenerative medicine and gene therapy, are now emerging as viable treatment options for patients with severe visual impairments, such as retinitis pigmentosa (RP). Gradable assessment of patients’ visual function is essential to consider treatment options and to evaluate treatment outcomes; however, evaluation of visual function in patients with advanced low vision is often challenging because of patients’ poor and sometimes unpredictable responses. In this study, we attempted to accurately assess visual capabilities and disease stage in patients with RP with a visual acuity (VA) of ≤ 0.01. DESIGN: Retrospective analysis of visual function indicators, including VA, retinal thickness, full-field stimulus testing (FST), and chromatic pupillometry. SUBJECTS: Overall, 43 patients (84 eyes) with advanced RP with a VA of ≤ 0.01 visited Kobe City Eye Hospital from 2019 to 2021. METHODS: Hierarchical (multilevel) Bayesian modeling was used to estimate individual eye’s pupil response and FST threshold, taking into account the ambiguity and randomness often observed in patients with ultralow vision. Using the estimated ability obtained from each test, the correlation between each test and retinal thickness was further analyzed to make a comprehensive assessment of the data. MAIN OUTCOME MEASURES: Visual acuity, retinal thickness, FST threshold, and pupil diameter change to different light stimuli. RESULTS: Full-field stimulus testing and pupillometry measurements were moderately correlated with VA but exhibited a wide range of values within the same VA groups. Full-field stimulus testing was not correlated with central retinal thickness at counting fingers/hand motion VA range and seemed to reflect overall remaining photoreceptor function, including peripheral retina. Pupillometry may be able to distinguish between different levels of inner retinal function. CONCLUSIONS: The combination of pupillometry and FST allowed for graded evaluation of visual function within patients grouped in the same VA groups in patients with advanced RP with ultralow vision. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
format Online
Article
Text
id pubmed-10618823
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106188232023-11-02 Detailed Evaluation of Chromatic Pupillometry and Full-Field Stimulus Testing to Assess Ultralow Vision in Retinitis Pigmentosa Yamamoto, Midori Matsuyama, Take Maeda, Tadao Takagi, Seiji Motozawa, Naohiro Sakai, Daiki Hirami, Yasuhiko Maeda, Akiko Kurimoto, Yasuo Takahashi, Masayo Mandai, Michiko Ophthalmol Sci Original Article PURPOSE: Novel therapeutic options, such as regenerative medicine and gene therapy, are now emerging as viable treatment options for patients with severe visual impairments, such as retinitis pigmentosa (RP). Gradable assessment of patients’ visual function is essential to consider treatment options and to evaluate treatment outcomes; however, evaluation of visual function in patients with advanced low vision is often challenging because of patients’ poor and sometimes unpredictable responses. In this study, we attempted to accurately assess visual capabilities and disease stage in patients with RP with a visual acuity (VA) of ≤ 0.01. DESIGN: Retrospective analysis of visual function indicators, including VA, retinal thickness, full-field stimulus testing (FST), and chromatic pupillometry. SUBJECTS: Overall, 43 patients (84 eyes) with advanced RP with a VA of ≤ 0.01 visited Kobe City Eye Hospital from 2019 to 2021. METHODS: Hierarchical (multilevel) Bayesian modeling was used to estimate individual eye’s pupil response and FST threshold, taking into account the ambiguity and randomness often observed in patients with ultralow vision. Using the estimated ability obtained from each test, the correlation between each test and retinal thickness was further analyzed to make a comprehensive assessment of the data. MAIN OUTCOME MEASURES: Visual acuity, retinal thickness, FST threshold, and pupil diameter change to different light stimuli. RESULTS: Full-field stimulus testing and pupillometry measurements were moderately correlated with VA but exhibited a wide range of values within the same VA groups. Full-field stimulus testing was not correlated with central retinal thickness at counting fingers/hand motion VA range and seemed to reflect overall remaining photoreceptor function, including peripheral retina. Pupillometry may be able to distinguish between different levels of inner retinal function. CONCLUSIONS: The combination of pupillometry and FST allowed for graded evaluation of visual function within patients grouped in the same VA groups in patients with advanced RP with ultralow vision. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references. Elsevier 2023-05-08 /pmc/articles/PMC10618823/ /pubmed/37920419 http://dx.doi.org/10.1016/j.xops.2023.100328 Text en © 2023 by the American Academy of Ophthalmology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Yamamoto, Midori
Matsuyama, Take
Maeda, Tadao
Takagi, Seiji
Motozawa, Naohiro
Sakai, Daiki
Hirami, Yasuhiko
Maeda, Akiko
Kurimoto, Yasuo
Takahashi, Masayo
Mandai, Michiko
Detailed Evaluation of Chromatic Pupillometry and Full-Field Stimulus Testing to Assess Ultralow Vision in Retinitis Pigmentosa
title Detailed Evaluation of Chromatic Pupillometry and Full-Field Stimulus Testing to Assess Ultralow Vision in Retinitis Pigmentosa
title_full Detailed Evaluation of Chromatic Pupillometry and Full-Field Stimulus Testing to Assess Ultralow Vision in Retinitis Pigmentosa
title_fullStr Detailed Evaluation of Chromatic Pupillometry and Full-Field Stimulus Testing to Assess Ultralow Vision in Retinitis Pigmentosa
title_full_unstemmed Detailed Evaluation of Chromatic Pupillometry and Full-Field Stimulus Testing to Assess Ultralow Vision in Retinitis Pigmentosa
title_short Detailed Evaluation of Chromatic Pupillometry and Full-Field Stimulus Testing to Assess Ultralow Vision in Retinitis Pigmentosa
title_sort detailed evaluation of chromatic pupillometry and full-field stimulus testing to assess ultralow vision in retinitis pigmentosa
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618823/
https://www.ncbi.nlm.nih.gov/pubmed/37920419
http://dx.doi.org/10.1016/j.xops.2023.100328
work_keys_str_mv AT yamamotomidori detailedevaluationofchromaticpupillometryandfullfieldstimulustestingtoassessultralowvisioninretinitispigmentosa
AT matsuyamatake detailedevaluationofchromaticpupillometryandfullfieldstimulustestingtoassessultralowvisioninretinitispigmentosa
AT maedatadao detailedevaluationofchromaticpupillometryandfullfieldstimulustestingtoassessultralowvisioninretinitispigmentosa
AT takagiseiji detailedevaluationofchromaticpupillometryandfullfieldstimulustestingtoassessultralowvisioninretinitispigmentosa
AT motozawanaohiro detailedevaluationofchromaticpupillometryandfullfieldstimulustestingtoassessultralowvisioninretinitispigmentosa
AT sakaidaiki detailedevaluationofchromaticpupillometryandfullfieldstimulustestingtoassessultralowvisioninretinitispigmentosa
AT hiramiyasuhiko detailedevaluationofchromaticpupillometryandfullfieldstimulustestingtoassessultralowvisioninretinitispigmentosa
AT maedaakiko detailedevaluationofchromaticpupillometryandfullfieldstimulustestingtoassessultralowvisioninretinitispigmentosa
AT kurimotoyasuo detailedevaluationofchromaticpupillometryandfullfieldstimulustestingtoassessultralowvisioninretinitispigmentosa
AT takahashimasayo detailedevaluationofchromaticpupillometryandfullfieldstimulustestingtoassessultralowvisioninretinitispigmentosa
AT mandaimichiko detailedevaluationofchromaticpupillometryandfullfieldstimulustestingtoassessultralowvisioninretinitispigmentosa